Category:Cancer treatments: Difference between revisions
From WikiMD's Wellness Encyclopedia
m 1 revision imported |
m 1 revision imported |
(No difference)
| |
Latest revision as of 06:35, 19 January 2025
Subcategories
This category has the following 8 subcategories, out of 8 total.
A
C
E
I
- Cancer immunotherapy (1 P)
R
- Radiation therapy (86 P)
S
- Surgical oncology (24 P)
T
- Targeted therapy (6 P)
V
- Cancer vaccines (14 P)
Pages in category "Cancer treatments"
The following 200 pages are in this category, out of 395 total.
(previous page) (next page)3
A
- Abituzumab
- ABT-510
- Active immunotherapy
- Active surveillance
- Active surveillance of prostate cancer
- Adc
- ADE (chemotherapy)
- Adecatumumab
- Adegramotide
- Adjuvant therapy
- Adoptive cell transfer
- Advaxis
- AFP-07
- AFPep
- ALECSAT
- ALK inhibitor
- Alpelisib
- Alternating electric field therapy
- Alternative cancer treatments
- Amatuximab
- AMG 319
- Amphinex
- Angiostatin
- Annamycin
- Anti-idiotypic vaccine
- Anti-VEGF
- Antibody–drug conjugate
- Antihormone therapy
- Template:Antineoplastic-agents-stub
- Asandeutertinib
- Asparaginase erwinia chrysanthemi
- ATC code L01
- Atrasentan
- Auger therapy
- Autologous immune enhancement therapy
- Autologous tumor cell
- Avapritinib
- Avicine
- Axicabtagene ciloleucel
B
C
- Camidanlumab tesirine
- Cancer Chemotherapy and Pharmacology
- Cancer drugs
- Cancer Treatment
- Cantuzumab
- Cantuzumab mertansine
- Cantuzumab ravtansine
- Capmatinib
- Capsaicin
- CAR T cell
- CAR-302,196
- Carmustine
- Carotuximab
- Cellular adoptive immunotherapy
- Che
- Chemoimmunotherapy
- Chemosensitizer
- Chemotherapy
- Cirmtuzumab
- Cisplatin
- Citatuzumab bogatox
- Cixutumumab
- Clevegen
- Clostridium novyi-NT
- Cofetuzumab pelidotin
- Coley's toxins
- Conatumumab
- Continuous hyperthermic peritoneal perfusion
- Cryoimmunotherapy
- Custirsen
- Cyberknife (device)
- Cytarabine
- Cytopenia
D
E
- Ecromeximab
- Edodekin alfa
- Edrecolomab
- Electrochemotherapy
- Emactuzumab
- Enadenotucirev
- Enavatuzumab
- Encorafenib
- Endoscopic mucosal resection
- Endostatin
- Engineered CAR T cell delivery
- Enoblituzumab
- Ensituximab
- Epigenetic therapy
- Erlizumab
- Ertumaxomab
- Estrogen deprivation therapy
- Etoposide
- Exagamglogene autotemcel
F
G
H
I
- Icrucumab
- Idecabtagene vicleucel
- Ifinatamab deruxtecan
- Image-guided radiation therapy
- IMEP (chemotherapy)
- Imexon
- IMM-101
- Immunotoxin
- Infigratinib
- Insulin potentiation therapy
- Internal radiation therapy
- Intetumumab
- Intraoperative electron radiation therapy
- Intraoperative radiation therapy
- Iratumumab
- IRGD peptides
- Irreversible electroporation
- Isolated organ perfusion technique
L
- Labetuzumab
- Leronlimab
- Lexatumumab
- Liarozole
- Limb perfusion
- Linifanib
- Linrodostat
- Lintuzumab
- Liposomal daunorubicin
- Lirentelimab
- Lirilumab
- Lisocabtagene maraleucel
- List of chemotherapeutic agents
- List of drugs: Y
- List of hormonal cytostatic antineoplastic agents
- Lomustine
- Loncastuximab tesirine
- Lorlatinib
- Lorvotuzumab mertansine
- Low-dose chemotherapy
- Lucatumumab
